Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR … – GlobeNewswire (press release)
EconoTimes |
Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR …
GlobeNewswire (press release) BRISBANE, Calif., April 16, 2018 (GLOBE NEWSWIRE) — Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments, today announced it … Humanigen, Inc. |
